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recommendations to these parents. Our naturalistic observational study confirms that 
ineffective pediatrician communication about HPV vaccination is common and identifies 
































Purpose.  We sought to establish which human papillomavirus (HPV) vaccine 
communication approaches by pediatricians were associated with same-day HPV 
vaccination of 11–12-year-olds by evaluating audio-recordings of visits.  
Methods. Verilogue, a market research company maintaining a panel of primary care 
pediatricians, provided audio-recordings and transcriptions of well-child visits for 11-12 
year old patients from January through June, 2013.  Seventy-five transcripts from 19 
pediatricians were coded for use of presumptive language (i.e., words conveying 
assumption of vaccine delivery), offer of delay, recommendation strength, and 
information provision. Using logistic regression, we evaluated the association between 
pediatrician communication approaches and agreement to same-day HPV vaccination. 
Generalized estimating equations (GEE) accounted for clustering of patients within 
pediatricians.  
Results. Same-day agreement to HPV vaccination occurred in 29% of encounters. 
Pediatricians in the sample often provided parents with inconsistent, mixed messages and 
sometimes offered information about HPV or HPV vaccination that was inaccurate. 
Pediatricians used presumptive language in only 11 of 75 encounters; when used, 
presumptive language was associated with higher odds of accepting HPV vaccine (73% 
vs. 22%, OR=8.96;95%CI=2.32-34.70). Pediatricians offered or recommended delay in 
the majority of encounters (65%). HPV vaccine acceptance occurred far more often when 
pediatricians did not mention delaying vaccination (82% vs. 6%; 
OR=80.84;95%CI=15.72-415.67). Same-day vaccination was not associated with 
strength of recommendation or pediatrician reference to vaccinating their own children.  
Conclusion. Our findings highlight the need to develop and evaluate physician-focused 












HPV vaccination coverage in the U.S. continues to be far below the Healthy People 2020 
target of 80% series completion by ages 13-15 [1,2]. To augment public health messaging 
campaigns, public health officials and clinicians seek to identify modifiable aspects of health 
care provider (HCP)-parent/patient communication about vaccination that may influence 
acceptance of HPV vaccination. 
Among parents’ most commonly reported reasons for non-vaccination are lack of 
physician offer/recommendation of HPV vaccine or physician acceptance of parental wish to 
delay [3-6]. Many physicians do not meet quality indicators, such as making a recommendation 
that is strong, timely (i.e., vaccination by ages 11-12), consistent across the patient panel (i.e., 
making routine rather than risk-based endorsement of vaccination) and urgent (recommending 
same-day rather than delayed vaccination) [7].  A recent systematic review underscored the 
importance of physician confidence about HPV vaccine communication [8]. However, as most of 
these studies involved HCP self-report, the quality of HPV vaccine communication may be even 
poorer than reported due to socially desirable responding [9,10]. Additionally, studies of parents’ 
recollections of their interactions with HCPs suggest that poor-quality communication is 
associated with lower HPV vaccine uptake [11]. 
In contrast to self-report and retrospective report of clinical encounters, objective 
observation of conversations between pediatricians, caregivers, and adolescents may clarify 
communication strategies that encourage or discourage vaccination uptake. For example, in an 
observational study that focused on early childhood immunization, the results indicated that 
using presumptive language (i.e., words conveying assumption of vaccine delivery) led to higher 




1) To describe the frequencies of pediatrician HPV vaccine communication behaviors;  
2) To evaluate the associations between pediatrician HPV vaccine communication 
behaviors and parental agreement to same-day HPV vaccination; and 
3) To describe common themes observed across pediatricians’ discussions about HPV 
vaccination. 
To meet these objectives, we used quantitative and qualitative analyses of audio-
recordings/transcripts of full clinical encounters between pediatricians, 11– 12-year-old patients, 
and their caregivers. 
METHODS 
Study Population and Transcript Preparation 
  The Point of Practice national physician panel maintained by Verilogue provided audio-
recordings and transcripts of patient visits between January and June 2013. The company gave 
pediatricians digital recording devices to audio-record entire well-child visits. After obtaining 
caregiver consent (any adult accompanying the minor patient to the well visit), the pediatrician 
audio-recorded the entire patient encounter. Separate conversations with nurses were not 
recorded. Families received compensation for their participation. Providers, caregivers, and 
patients were unaware that analysis of the recordings would focus specifically on HPV vaccine 
communication. Pediatricians securely transmitted patient visit audio-recording to Verilogue, 
along with patient age, race, ethnicity, and insurance type as well as pediatrician sex, years in 
practice, and practice type. The company de-identified personal information for the patient and 
pediatricians and provided us with transcripts of entire patient encounters with pediatricians. The 
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study received exempt status from institutional review boards at Indiana University and 
University of North Carolina.  
The Verilogue participant panel included 44 board-certified pediatricians from across the 
nation; 20 of these pediatricians had patient visits during the study period with 11-12 year olds, 
resulting in a sample of encounters with 100 patients. Of these encounters, 25 were excluded 
because a caregiver was not present during the visit, discussion did not touch on vaccination of 
the child, or the child started the HPV vaccination series at a prior visit. This resulted in 75 
usable transcripts from 19 providers.  
Transcript coding 
 Using a directed qualitative analysis approach [13], we developed categorical codes to 
characterize HPV vaccine communication approaches and themes of interest based on prior 
research on physician-parent communication regarding vaccination [7,12,14,15]. The codes 
captured whether the pediatrician: (a) used presumptive vs. non-presumptive language;  (b) 
recommended HPV vaccine (i.e., strong, moderate, weak, or no recommendation); (c) 
offered/recommended delay of vaccination; (d) used a risk-based approach to the need for HPV 
vaccination; (e) provided information, including misinformation, about HPV infection or 
vaccination; (f) responded to parent hesitancy with, for example, immediate acquiescence, 
provision of additional information, or elicitation of specific parent concerns with the goal of 
vaccine acceptance; (g) specifically mentioned sexual transmission of HPV; (h) shared personal 
vaccination practices (i.e., pediatrician vaccinating own or future offspring); and (i) engaged in 
lengthy scientific monologues about HPV vaccination. 
 The investigators jointly developed a provisional code book of categorical definitions for 
each code.  Examples of quotes that correspond to codes appear in Table 1. To insure reliability, 
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pairs of coders (MK, KD, & LS) independently coded 20 of the transcripts to confirm similar 
approaches to coding. Initial inter-coder percent agreement was .80 or better for all but one 
category.  The team resolved discrepancies through discussion until consensus and recoded 
transcripts accordingly. 
Quantitative Measures 
 The outcome of interest, vaccine acceptance, was defined as same-day caregiver 
agreement to HPV vaccination. Definite acceptance was a caregiver statement of wanting the 
vaccination for the child or agreement with a provider recommendation, (e.g., “ok”, “uh huh”); 
and we assumed probable acceptance when the caregiver did not make a verbal statement of 
refusal. Codings of definite and probable comprised the category “accepted.” Caregiver 
statements of definite refusal (e.g. “I don’t want that one”, “no”) or those coded “unclear” were 
combined into the category “not accepted”. Medical chart data submitted by participating 
pediatricians did not include documentation of vaccination at the medical encounter. 
 Predictors included the following subset of categories, which lent themselves to 
quantitative coding: 
Presumptive Approach.  A presumptive approach featured a matter-of-fact statement that 
the child was due for or would receive HPV vaccine that day or at a future date, conveying a 
positive stance toward vaccination (e.g., “The ones you’re getting are an Adacil, Menactra and 
the HPV”; “The HPV—you will get that next time”). In contrast, a non-presumptive style 
involved questions or uncertainty (e.g., “And you could get HPV. Do you want [it]? Have you 
thought about [it]? Are we doing HPV today?”  (See Table 1 for additional examples). 
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Strength of Recommendation.  Weak recommendations featured passive voice (e.g., “it is 
recommended”) or third-person attribution of recommendation (e.g., “professional organizations 
recommend”). Moderate recommendations required a first-person singular or plural statement 
(e.g. “I/we recommend.”) Strong recommendations involved first-person singular or plural 
statement as well as emphasis words such as “strongly” or “definitely,” (e.g., “I strongly 
recommend that he gets the HPV vaccine”). Mentioning HPV vaccine without a clear 
endorsement was not considered a recommendation. 
Offer of Delayed Vaccination. Offer of delay occurred when pediatricians stated that the 
parent could choose to vaccinate at a later point or clearly recommended that the parent wait to 
vaccinate until later (e.g., “I usually wait 'til 13 on that one [HPV].”)  In a few cases in which 
pediatrician discourse could not be clearly coded, “no delay” was assigned. 
Reference to Vaccinating Own Child.  This code included instances when pediatricians 
referred to having their own child receive HPV vaccine or stated that they would vaccinate their 
child if they had children (e.g., “I’ve done my two girls. I haven’t done my boys yet but probably 
will in the next few years”). 
Quantitative Data Analysis 
The unit of analysis was patient visit. Logistic regression analyses assessed the following 
four pediatrician behaviors as potential predictors of parental agreement to HPV vaccination: 
presumptive approach, strength of recommendation, offer of delay, and reference to vaccinating 
own child. Analyses used generalized estimating equations to account for correlated data due to 
the clustering of patients within pediatricians. Child sex differences in offer of delay and strength 
of recommendation were examined with chi-square analyses. Using chi-square analyses, we 
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examined whether particular communication behaviors systematically co-occurred—presumptive 
approach, strength of recommendation, and offer of delay. 
RESULTS 
Pediatricians were experienced, all from private practices in urban settings, located 
predominantly in the Midwest and South (Table 2). The majority of well-child visits were with 
white patients; 34 were with girls (45%) and 41 boys (55%) ages 11 or 12. Less than a third of 
the visits (29%) resulted in same-day vaccine acceptance, which was not associated with patient 
sex (p=.45). 
 Qualitative Analysis of Pediatrician Discussion of HPV Vaccine 
 Pediatrician communication about HPV vaccine created impressions of “mixed 
messages” and pediatricians were often inconsistent in their communication approaches across 
patients. Pediatricians often made recommendations alongside an offer/recommendation of 
delay, in effect diluting the initial recommendation (see Table 1).  Pediatricians often treated 
HPV vaccine differently from Tdap and meningococcal conjugate vaccine.  (Hepatitis A and 
seasonal influenza vaccines were discussed infrequently.) Pediatricians portrayed non-HPV 
vaccines as “required by school/camp” or “routine” but HPV vaccine as “optional”, a matter of 
parent choice. One provider, after giving a brief, presumptive recommendation for two vaccines, 
said “Gardasil is the one to discuss.”  Pediatricians more often referred to mode of transmission 
for HPV infection than for other vaccine-preventable diseases. Some pediatricians made direct 
statements about sexually transmitted infection or sexual transmission (e.g., “It is sexually 
transmitted and girls and boys pass it back and forth”), but many statements were less direct (see 
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Table 1) and involved vague links between vaccination timing and projected future sexual 
relationships (e.g., “He’s not at the age where he’s doing anything immediately”).  
A few pediatricians discussed HPV vaccine as they did other vaccines, employing a brief, 
matter-of-fact presumptive style with HPV vaccine at the end of a list of vaccines for which the 
child was “due”. These providers tended to offer a strong recommendation (e.g., “It’s not 
required but strongly recommended”), even in cases where they accommodated the parent’s 
desire to delay (e.g., “ok…Eventually she will get the Gardasil”).  
 Back-and-forth dialogue about HPV vaccine in which parental questions or concerns 
were elicited was not the norm. Instead, pediatricians sometimes provided a monologue of 
scientific facts (See Table 1.) Information about other vaccines was usually limited to, “It guards 
against (disease).” Misinformation about duration of protection and cancer targets was common 
(e.g., “HPV causes colon cancer”; “The vaccine covers 100% for life.”) Some pediatricians 
referred to their personal decisions to vaccinate their own or future children against HPV, an 
approach not used with other adolescent vaccines. 
Many pediatricians offered or recommended delaying vaccination before caregivers 
voiced any reaction to HPV vaccine such that caregivers agreed with delaying rather than 
directly voicing refusal of an offered vaccine. Common rationales for delay included the child 
being “too young” and that children the patient’s age were not at risk for sexual behavior.  Some 
of these pediatricians seemed to hold preconception that they must introduce HPV vaccine 
gradually over multiple visits. They made reference to either discussing HPV vaccine at a prior 
visit or voiced an intention to familiarize the family with the topic at the current visit, with plans 
to revisit the vaccination decision at a future visit. 
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When pediatricians encountered caregiver hesitancy or concern about possible side 
effects of HPV vaccine, they typically acquiesced at once.  A few pediatricians explored the 
parents’ concerns (e.g., “So what kind of questions do you…have about it that you’re unsure? 
Why don’t you want to do it?”). One pediatrician leveraged the parent’s stated desire to discuss 
the vaccine with her daughter at home by offering written material to review at home after the 
vaccination occurred. 
Few caregivers independently raised the topic of HPV vaccination. One pediatrician 
began with “The only other vaccine that we don’t have to do this year, um, but actually” to 
which the caregiver responded “HPV” and then asked about her son’s history of warts (non-
genital).  
Predictors of Same-Day HPV Vaccine Acceptance 
Pediatricians employed a presumptive approach in 11 of 75 visits (Table 3). Visits where 
a pediatrician used presumptive language had HPV vaccine acceptance 73% of the time, whereas 
acceptance occurred only 22% of the time when presumptive language was not used. A 
presumptive approach was associated with 9 times greater odds of same-day vaccination 
(OR=8.96; 95% CI=2.32-34.70).  
Pediatricians mentioned delay of HPV vaccination in 49 of 75 visits. When delay of 
vaccination was offered or recommended, only 6% of caregivers agreed to vaccinate, compared 
to 82% agreement when delay was not mentioned. With no mention of delay, odds of agreement 
to vaccination were 81 times greater (OR=80.84; 95%CI=15.72-415.67). Strength of 
recommendation (p=.94) and pediatrician reference to vaccinating own children (p=.58) were not 
associated with HPV vaccine acceptance. Use of presumptive language, strength of 
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recommendation, and offer of delay co-occurred in unexpected ways. Some providers who 
adopted a presumptive approach mentioned but did not directly recommend the vaccine. In the 
visits in which pediatricians used presumptive language, visits were split between no 
recommendation (6 of 11, 55%) and endorsement of HPV vaccine (5 of 11; 45%).  Offering 
delay occurred in only 2 of 11 presumptive language visits (18%). In contrast, offering delay 
accompanied 47 of 64 non-presumptive language visits (73%). In the encounters in which 
pediatricians did not recommend the vaccine, 60% (15 of 25) offered delay.  
 No patient sex differences were found in pediatrician offer of delay (p=.88), 
presumptive recommendation (p=.62), or strength of recommendation (p=.45). 
DISCUSSION 
Our research showed that offering to delay HPV vaccination and failure to use 
presumptive language were very strong predictors of non-acceptance of vaccine. The findings in 
this research extend those reported by two prior studies that also analyzed audio-recorded HPV 
vaccination discussions between patients/parents and providers. Whereas those studies examined 
both adolescent and adult women (11-26 year) [14] or adolescent females and males spanning 11 
to 17 years [16], we focused specifically on patients ages 11–12, the ages when HPV vaccination 
is routinely recommended.  Moreover, our larger sample size of early adolescents allowed us to 
conduct both qualitative and quantitative analyses. Lastly, we sampled physicians from many 
different geographical locations within the United States rather than from a single health system 
of clinics in a single city [16], improving potential generalizability of findings.  
 A geographically diverse sample of pediatricians seeing children ages 11 and 12, 
typically conveyed a mixed message about HPV vaccine by treating it differently from other 
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vaccines, offering to delay or acquiescing to parental desire for delay, and failing to make clear, 
strong recommendations.  Few used presumptive language that the child is due for HPV 
vaccination, even though this was associated with higher same-day vaccination [12,17]. 
Although many pediatricians in our sample provided at least basic information about the vaccine 
or HPV infection, their communications often had factual inaccuracies, used risk-based 
language, and inconsistently educated about the vaccine preventing one or more cancers. 
Research documents physician anticipation of parental hesitancy regarding HPV vaccination 
[8].  It is possible that expectations of parental resistance to pediatricians’ recommendations may 
discourage some pediatricians from communicating clearly about certain issues. For example, 
Mangione-Smith et al. found that physician perception of parental desire to have an antibiotic 
prescribed for their child often did not match parental expectations [18]. Similarly, Healy et al. 
reported that health care providers particularly and significantly underestimated parental interest 
in HPV vaccination compared to other vaccines [19]. Gilkey and colleagues found that only 13% 
of providers felt that parents viewed HPV vaccine as important for their child’s health [15]. 
Some pediatricians may cope with their expectation of parental hesitancy about, or resistance to, 
HPV vaccination by gradually introducing the topic to parents.  We suggest that when 
pediatricians expect parental hesitancy, they may actually fuel parental hesitancy and reduce the 
likelihood of vaccine acceptance – a self-fulfilling prophecy. 
Limitations include use of a selected sample of pediatricians and no medical record 
verification of same-day vaccination. The modest sample size prevented us from conducting 
analyses adjusted for sociodemographic characteristics and contributed to large confidence 
intervals in the logistic regression analyses.  Future studies could include a probability sample of 
providers to help ensure generalizability, more audio-recordings per physician, and access to 
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medical records or state vaccination registries for vaccination verification. It would also be 
useful to examine the role of adolescent patients in conversations about vaccine decisions. Our 
impression was that patients were more likely to voice distress about getting shots in general 
than resistance to HPV vaccine. Future research should examine communication styles of other 
vaccine-provider professionals, including family physicians, nurses, and pharmacists. Given that 
we found that pediatricians demonstrated inconsistency in communication behaviors across 
patients, it would be helpful to better understand which physician, caregiver, and patient 
characteristics drive physicians’ use of different communication behaviors with different 
families. Physicians, caregivers, and patients being unaware of the research focus on HPV 
vaccination lends credibility to our data and largely eliminates the problem of socially desirable 
responding. 
The findings from this study are consistent with, and add substantially to, the emerging 
literature on physician-family communication about HPV vaccination. This study identifies 
urgency and presumptive communication as critical for motivating same-day HPV vaccination. 
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Table 1. Example quotes for communication behaviors 
Communication Behavior Example Quotes 
Presumptive Style Yes:  
“Got a couple of shots today. The ones you’re getting are an Adacil, Menactra and the HPV”. 
(girl; female MD from GA, 21-30 years practice); 
 
“We’ve got tetanus, meningitis, the HPV. And we can get that going for you” (girl; male MD 
from SC, 21-30 years practice)  
 
No:  
“the HPV, which is the Gardasil you absolutely do not need to do at [AGE} years of age” 
(boy; male MD from FL, 11-20 years practice); 
 
”Can I interest you at all in Gardasil shot?” (girl; male MD from FL, 11-20 years practice) 
Recommendation Strength Weak: “they do recommend it for boys” (boy, male MD from FL, 11-20 years practice) 
 
Moderate: “I think it’s an important vaccine & I think it’s good, ok.” (boy, male MD from FL 
with 11-20 years practice) 
 
Strong: “I do however recommend it completely between now and being 18” (male, female 
MD from IN, 11-20 years practice). 
Offers to delay vaccination “I know the nurse wrote down all these different vaccines. You obviously do not have to do 
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all of them (laugh). Uh, the HPV which is the Gardasil, you absolutely do not need to do at 
this age…there is no urgency in a [AGE] to do it (laugh).” (boy; male MD from FL, 11-20 
years practice) 
 
“I like that & I would like for her to have that but I don’t care when.” (girl; female MD from 
GA, 21-30 years practice)  
Risk-based approach to need 
for HPV vaccine 
“She’s not at an age where she is going to be having any risk factors.” (girl; male MD from 
WI, 11-20 years practice) 
 
“But as long as it’s before he’s sexually active which he better not be because then he’d have 
to answer to his pediatrician and his mama.” (boy, male MD from GA, 21-30 years practice)  
Provides information about 
HPV infection or vaccine 
“There’s not, as far as we know, there’s not a genetic predisposition.” (girl, male MD from 
WI, 11-20 years practice)  
 
“They do now recommend Gardasil for boys. It’s approved from the FDA from 9 all the way 
up to 28.” (girl; female MD from FL, 11-20 years practice) 
 
“It’s the one for cervical cancer to prevent the virus that causes that one.” (girl, female MD 
from GA, 21-30 years  practice) 
 
Provides misinformation “It’s good at any age” (girl; female MD from GA, 21-30 years practice) 
 
“Other research looking at the uterine & ovarian cancer with the HPV causing some of that 
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too (boy; male MD from TX, 21-30 years practice) 
 
“Women can actually pick up cancer from this vaccine.”(boy; male MD from SC, 21-30 years 
practice) 








MD: “..and then eventually the Gardasil shot. That’s the cervical cancer vaccine.” CG: “no”. 
MD: “OK.”. CG: ”No, we are definitely skipping it.” MD: “So one today, the tetanus?” (girl; 
male MD from IL, 11-20 years practice). 
 
CG: “I’m just making sure that it didn’t make him grow boobies or anything like that”. MD: 
“no, it won’t do nothing bad, do nothing bad.” (boy, female MD from OH, 21-30 years 
practice) 
 
MD: ”So what kind of questions do you have about it that you‘re unsure? Why don’t you 
want to do it? “(girl; male MD from NC, 31+ years practice) 
 
HPV-sexual activity linkage 
 
 
“Well, the thing is, it protects, the virus is passed back and forth between boys & girls.” 
(male, female MD from SC, 3-10 years practice) 
 
“You’ve got to get that in there before they enter that stage of life” (boy, male MD from OH, 
21-30 years practice) 
 
“And it’s not, most of the time you hear about it being transmitted sexually, but not all cases.” 




Personal Vaccination Practice 
 
”Doctors ain’t supposed to say this but for what it’s worth, my two teenage boys have gotten 
it. You know?” (boy; male MD from OH, 21-30 years practice) 
 
“As far as I’m concerned, if I had any boys they’d, you know, they’d be getting it. Both my 
daughters got theirs at, as soon as it became available.“  (boy, male MD from AZ; 21-30 years 
practice) 
 
Scientific Monologue “Okay. Yeah, it's funny, I was talking to a father a few months ago, um, his boy actually came 
in for a college physical. He just got accepted to college and decided he wanted to come in. 
Um, and sort of at the end of our visit I said to him I just wanted to let you know that the 
cervical cancer vaccine for girls, which has been around for about nine years or something 
like that, uh, just got approved for boys two years ago. And he looks at me and he says, well 
the last time I checked my boy doesn't have a cervix. Uh, yeah and I said, yeah, I realize that. 
But do you have any girls? He said, yeah, I have a daughter. And I said, I'll tell you what, let's 
not do any of the girls. Just do all the boys. …You know, boys get it and they generally have 
no symptoms other than they give it to the girls and then the girls can get cervical cancer. 
There is a slight like, um, increased risk of like cancer of the penis and cancer of the anus with 




Table 2. Patient and Pediatrician Characteristics 
 
Patients (n=75) n (%) 
Sex 
 Male 41 (55) 
Female 34 (45) 
Insurance Type 
 Preferred Provider Organization (PPO) 38 (51) 
Medicaid 16 (21) 
Private 12 (16) 
Health maintenance organization (HMO) 8 (11) 
No insurance 1 (1) 
Race 
 White 55 (73) 
Black/African American 11 (15) 
Mexican/Puerto Rican/Other Hispanic 6 (8) 
Middle-Eastern/Other Asian 3 (4) 
  Pediatricians (n=19) 
 Gender 
 Male 15 (79) 
Female 4 (21) 
Years in Practice 
 3 -10 1 (5) 
11-20 8 (42) 
21-30 8 (42) 





South 9 (47) 
Midwest 7 (37) 
Northeast 2 (11) 
West 1 (5) 
  # of Transcripts per Pediatrician 






Table 3. Prevalence of communication styles 
  
Communication Style N (%) N (%) vaccinated 
Strength of Recommendation   
   No Recommendation 25 (33%) 7 (28%) 
   Weak 19 (25%) 5 (26%) 
   Moderate 26 (35%) 8 (31%) 
   Strong 5 (7%) 2 (40%) 
Presumptive Language   
   Yes 11 (15%) 8 (73%) 
   No 64 (85%) 14 (22%) 
Offer of Delay   
   Yes  49 (65%) 3 (6%) 
   No/Unclear 26 (35%) 19 (73%) 
Reference to Vaccinating Own Child    
   Yes  13 (17%) 3 (23%) 
   No 62 (83%) 19 (31%) 
 
 
